New York, USA, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Global Neuromodulation Devices Market Anticipating Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight The neuromodulation devices market is ...

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

The demand for advanced Neurodegenerative Disease Devices is being significantly driven by the growing burden of progressive neurological disorders across developed healthcare economies. Rapid ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults worldwide.

Given the growing interest in non-invasive neuromodulation devices for the central nervous system, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 2-3, 2015 to ...

PLANO, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, ...

Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among ...

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) today announced U.S. Food and Drug Administration (FDA) De Novo authorization to market the Quell neuromodulation device as an ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Neuromodulation offers personalized, responsive ...